Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2000 Sep;55(9):751–754. doi: 10.1136/thorax.55.9.751

Epidemiology of familial sarcoidosis in the UK

D McGrath 1, Z Daniil 1, P Foley 1, J L du Bois 1, P Lympany 1, P Cullinan 1, R M du Bois 1
PMCID: PMC1745852  PMID: 10950893

Abstract

BACKGROUND—The last comprehensive epidemiological studies on familial sarcoidosis in the UK were more than 25 years ago, reporting another affected family member in 1.7% of index cases. A significant proportion of like-sex over unlike-sex pairs, an excess of mother-child over father-child associations, and a preponderance of monozygous over dizygous twins was noted. Another study reported ethnic heterogeneity in familial disease. This study was undertaken to identify the risk ratio (λS) for siblings of familial sarcoidosis in the UK, to determine if the previous epidemiological findings have persisted, and to reassess whether ethnic heterogeneity prevails in familial disease.
METHOD—Questionnaires were sent to 406 index patients.
RESULTS—Two hundred and sixty eight replies (66%) were received. Twenty four of the original 406 index patients (5.91%) were found to have at least one other relative (first, second or third degree) with biopsy proven sarcoidosis. A λS value of 36-73 was calculated indicating significant familial clustering of the disease. Ethnically the families comprised 62.5% Caucasian, 29.2% Afro-Caribbean, and 8.3% Asian. Mean age at diagnosis was 39.8 years for women and 40.9 years for men with a male to female ratio of 1:1.7. This differed for the Asian families in which all the affected members were male. Three sets of female twins (two monozygous and one dizygous) were included. There was an equal distribution of like-sex (primarily female) and unlike-sex families as well as mother-child and father-child pairs. Pulmonary involvement was predominant irrespective of ethnicity, as was the need for corticosteroid treatment.
CONCLUSIONS—These results support the theory that a shared determinant (either genetic or environmental) is operating in familial sarcoidosis and suggest that this determinant is similar for all ethnic groups.



Full Text

The Full Text of this article is available as a PDF (135.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avila J. J., Lympany P. A., Pantelidis P., Welsh K. I., Black C. M., du Bois R. M. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol. 1999 Jan;20(1):106–112. doi: 10.1165/ajrcmb.20.1.3232. [DOI] [PubMed] [Google Scholar]
  2. Berlin M., Fogdell-Hahn A., Olerup O., Eklund A., Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 1997 Nov;156(5):1601–1605. doi: 10.1164/ajrccm.156.5.9704069. [DOI] [PubMed] [Google Scholar]
  3. Brennan N. J., Crean P., Long J. P., Fitzgerald M. X. High prevalence of familial sarcoidosis in an Irish population. Thorax. 1984 Jan;39(1):14–18. doi: 10.1136/thx.39.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Edmondstone W. M., Wilson A. G. Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest. 1985 Jan;79(1):27–36. doi: 10.1016/0007-0971(85)90004-x. [DOI] [PubMed] [Google Scholar]
  5. Familial associations in sarcoidosis. A report to the Research Committee of the British Thoracic and Tuberculosis Association. Tubercle. 1973 Jun;54(2):87–98. doi: 10.1016/0041-3879(73)90030-5. [DOI] [PubMed] [Google Scholar]
  6. Foley P. J., Lympany P. A., Puscinska E., Zielinski J., Welsh K. I., du Bois R. M. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit Care Med. 1999 Sep;160(3):1009–1014. doi: 10.1164/ajrccm.160.3.9810032. [DOI] [PubMed] [Google Scholar]
  7. LOFGREN S. Primary pulmonary sarcoidosis. I. Early signs and symptoms. Acta Med Scand. 1953;145(6):424–431. [PubMed] [Google Scholar]
  8. McNicol M. W., Luce P. J. Sarcoidosis in a racially mixed community. J R Coll Physicians Lond. 1985 Jul;19(3):179–183. [PMC free article] [PubMed] [Google Scholar]
  9. Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J. 1998 Sep;12(3):716–738. doi: 10.1183/09031936.98.12030716. [DOI] [PubMed] [Google Scholar]
  10. Newman L. S. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis. 1995 Mar;12(1):7–19. [PubMed] [Google Scholar]
  11. Pietinalho A., Ohmichi M., Hirasawa M., Hiraga Y., Löfroos A. B., Selroos O. Familial sarcoidosis in Finland and Hokkaido, Japan--a comparative study. Respir Med. 1999 Jun;93(6):408–412. doi: 10.1053/rmed.1999.0579. [DOI] [PubMed] [Google Scholar]
  12. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet. 1990 Feb;46(2):229–241. [PMC free article] [PubMed] [Google Scholar]
  13. Rybicki B. A., Harrington D., Major M., Simoff M., Popovich J., Jr, Maliarik M., Iannuzzi M. C. Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol. 1996;13(1):23–33. doi: 10.1002/(SICI)1098-2272(1996)13:1<23::AID-GEPI3>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  14. Rybicki B. A., Major M., Popovich J., Jr, Maliarik M. J., Iannuzzi M. C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997 Feb 1;145(3):234–241. doi: 10.1093/oxfordjournals.aje.a009096. [DOI] [PubMed] [Google Scholar]
  15. Teirstein A. S., Siltzbach L. E., Berger H. Patterns of sarcoidosis in three population groups in New York City. Ann N Y Acad Sci. 1976;278:371–376. doi: 10.1111/j.1749-6632.1976.tb47048.x. [DOI] [PubMed] [Google Scholar]
  16. Todd J. A. Lawrence Lecture. The Emperor's new genes: 1993 RD Lawrence Lecture. Diabet Med. 1994 Jan-Feb;11(1):6–16. doi: 10.1111/j.1464-5491.1994.tb00222.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES